| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.2 |